|
1
|
Numakawa T, Odaka H and Adachi N: Actions
of brain-derived neurotrophin factor in the neurogenesis and
neuronal function, and its involvement in the pathophysiology of
brain diseases. Int J Mol Sci. 19:36502018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colucci-D'Amato L, Speranza L and
Volpicelli F: Neurotrophic factor BDNF, physiological functions and
therapeutic potential in depression, neurodegeneration and brain
cancer. Int J Mol Sci. 21:77772020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kasemeier-Kulesa JC, Spengler JA, Muolo
CE, Morrison JA, Woolley TE, Schnell S and Kulesa PM: The embryonic
trunk neural crest microenvironment regulates the plasticity and
invasion of human neuroblastoma via TrkB signaling. Dev Biol.
480:78–90. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jia S, Wang W, Hu Z, Shan C, Wang L, Wu B,
Yang Z, Yang X and Lei D: BDNF mediated TrkB activation contributes
to the EMT progression and the poor prognosis in human salivary
adenoid cystic carcinoma. Oral Oncol. 51:64–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reichardt LF: Neurotrophin-regulated
signalling pathways. Philos Trans R Soc Lond B Biol Sci.
361:1545–1564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sinkevicius KW, Kriegel C, Bellaria KJ,
Lee J, Lau AN, Leeman KT, Zhou P, Beede AM, Fillmore CM, Caswell D,
et al: Neurotrophin receptor TrkB promotes lung adenocarcinoma
metastasis. Proc Natl Acad Sci USA. 111:10299–10304. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xiong L, Deng X, Wen Y, Yang Z and Miao X:
Association of BDNF and BMPR1A with clinicopathologic parameters in
benign and malignant gallbladder lesions. World J Surg Oncol.
11:802013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carrasco C, Tittarelli A, Paillaleve N,
Pozo MD, Rojas-Sepúlveda D, Barría O, Fluxá P, Hott M, Martin C,
Quezada C and Salazar-Onfray F: The evaluation of 17
gastrointestinal tumor markers reveals prognosis value for MUC6,
CK17, and CD10 in gallbladder-cancer patients. Diagnostics (Basel).
11:1532021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Srivastava K, Srivastava A, Sharma KL and
Mittal B: Candidate gene studies in gallbladder cancer: A
systematic review and meta-analysis. Mutat Res. 728:67–79. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Artico M, Bronzetti E, Alicino V, Ionta B,
Bosco S, Grande C, Bruno M, Leali FM, Ionta G and Fumagalli L:
Human gallbladder carcinoma: Role of neurotrophins, MIB-1, CD34 and
CA15-3. Eur J Histochem. 54:e102010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawamoto M, Onishi H, Ozono K, Yamasaki A,
Imaizumi A, Kamakura S, Nakano K, Oda Y, Sumimoto H and Nakamura M:
Tropomyosin-related kinase B mediated signaling contributes to the
induction of malignant phenotype of gallbladder cancer. Oncotarget.
8:36211–36224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watson P, Vasen HFA, Mecklin JP, Bernstein
I, Aarnio M, Järvinen HJ, Myrhøj T, Sunde L, Wijnen JT and Lynch
HT: The risk of extra-colonic, extra-endometrial cancer in the
Lynch syndrome. Int J Cancer. 123:444–449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim ET, Namgung H, Shin HD, Lee SI, Kwon
JE, Chang MC and Park DG: Oncologic manifestations of
neurofibromatosis type 1 in Korea. J Korean Surg Soc. 82:205–210.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lowenfels AB, Maisonneuve P, Boyle P and
Zatonski WA: Epidemiology of gallbladder cancer.
Hepatogastroenterology. 46:1529–1532. 1999.PubMed/NCBI
|
|
15
|
Laitio M: Histogenesis of epithelial
neoplasms of human gallbladder I. Dysplasia. Pathol Res Pract.
178:51–56. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Albores-Saavedra J, Alcántra-Vazquez A,
Cruz-Ortiz H and Herrera-Goepfert R: The precursor lesions of
invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia
and carcinoma in situ. Cancer. 45:919–927. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roa I, de Aretxabala X, Araya JC and Roa
J: Preneoplastic lesions in gallbladder cancer. J Surg Oncol.
93:615–623. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Watanabe H, Date K, Itoi T, Matsubayashi
H, Yokoyama N, Yamano M, Ajioka Y and Nishikura K: Histological and
genetic changes in malignant transformation of gallbladder adenoma.
Ann Oncol. 10 (Suppl 4):S136–S139. 1999. View Article : Google Scholar
|
|
19
|
Barreto SG, Dutt A and Chaudhary A: A
genetic model for gallbladder carcinogenesis and its dissemination.
Ann Oncol. 25:1086–1097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Moraes JK, Wagner VP, Fonseca FP,
Vargas PA, de Farias CB, Roesler R and Martins MD: Uncovering the
role of brain-derived neurotrophic factor/tyrosine kinase receptor
B signaling in head and neck malignancies. J Oral Pathol Med.
47:221–227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao F, Chen X, Li X, Deng C and Luo P: The
pro-migratory and pro-invasive roles of cancer-associated
fibroblasts secreted IL-17A in prostate cancer. J Biochem Mol
Toxicol. 39:e700472025. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai Q, Shi L, Zhang M and Chen P:
Multi-scale transcriptomics reveals that specific tumor cells
promote lung adenocarcinoma metastasis through crosstalk with the
microenvironment. Discov Oncol. 15:5202024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ibi H, Takahashi K, Harada H, Watabe T and
Podyma-Inoue KA: Transforming growth factor-β signals promote
progression of squamous cell carcinoma by inducing
epithelial-mesenchymal transition and angiogenesis. Biochem Biophys
Res Commun. 714:1499652024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang F, Sun L, Li Q, Han X, Lei L, Zhang H
and Shang Y: SET8 promotes epithelial-mesenchymal transition and
confers TWIST dual transcriptional activities. EMBO J. 31:110–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smit MA, Geiger TR, Song JY, Gitelman I
and Peeper DS: A twist-snail axis critical for TrkB-induced
epithelial-mesenchymal transition-like transformation, anoikis
resistance, and metastasis. Mol Cell Biol. 29:3722–3737. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bao W, Qiu H, Yang T, Luo X, Zhang H and
Wan X: Upregulation of TrkB promotes epithelial-mesenchymal
transition and anoikis resistance in endometrial carcinoma. PLoS
One. 8:e706162013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li T, Yu Y, Song Y, Li X, Lan D, Zhang P,
Xiao Y and Xing Y: Activation of BDNF/TrkB pathway promotes
prostate cancer progression via induction of epithelial-mesenchymal
transition and anoikis resistance. FASEB J. 34:9087–9101. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moriwaki K, Wada M, Kuwabara H, Ayani Y,
Terada T, Higashino M, Kawata R and Asahi M: BDNF/TRKB axis
provokes EMT progression to induce cell aggressiveness via
crosstalk with cancer-associated fibroblasts in human parotid gland
cancer. Sci Rep. 12:175532022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang WJ, Luo C, Huang C, Pu FQ, Zhu JF
and Zhu ZM: PI3K/Akt/GSK-3β signal pathway is involved in P2X7
receptor-induced proliferation and EMT of colorectal cancer cells.
Eur J Pharmacol. 899:1740412021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Andreska T, Lüningschrör P and Sendtner M:
Regulation of TrkB cell surface expression-a mechanism for
modulation of neuronal responsiveness to brain-derived neurotrophic
factor. Cell Tissue Res. 382:5–14. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim YN, Koo KH, Sung JY, Yun UJ and Kim H:
Anoikis resistance: An essential prerequisite for tumor metastasis.
Int J Cell Biol. 2012:3068792012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu JY, Wang SZ, Yuan HQ, Li JL and Xing
PY: Patients with non-small cell lung cancer with the exon 21 L858R
mutation: From distinct mechanisms to epidermal growth factor
receptor tyrosine kinase inhibitor treatments (Review). Oncol Lett.
29:1092024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yuan Y, Ye HQ and Ren QC: Proliferative
role of BDNF/TrkB signaling is associated with anoikis resistance
in cervical cancer. Oncol Rep. 40:621–634. 2018.PubMed/NCBI
|
|
35
|
Frisch SM, Schaller M and Cieply B:
Mechanisms that link the oncogenic epithelial-mesenchymal
transition to suppression of anoikis. J Cell Sci. 126:21–29. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Anastasia A, Deinhardt K, Wang S, Martin
L, Nichol D, Irmady K, Trinh J, Parada L, Rafii S, Hempstead BL and
Kermani P: Trkb signaling in pericytes is required for cardiac
microvessel stabilization. PLoS One. 9:e874062014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin CY, Hung SY, Chen HT, Tsou HK, Fong
YC, Wang SW and Tang CH: Brain-derived neurotrophic factor
increases vascular endothelial growth factor expression and
enhances angiogenesis in human chondrosarcoma cells. Biochem
Pharmacol. 91:522–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsai YF, Tseng LM, Hsu CY, Yang MH, Chiu
JH and Shyr YM: Brain-derived neurotrophic factor (BDNF)-TrKB
signaling modulates cancer-endothelial cells interaction and
affects the outcomes of triple negative breast cancer. PLoS One.
12:e01781732017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aygun N: Biological and genetic features
of neuroblastoma and their clinical importance. Curr Pediatr Rev.
14:73–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Garrido MP, Torres I, Vega M and Romero C:
Angiogenesis in gynecological cancers: Role of neurotrophins. Front
Oncol. 9:9132019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Łuczkowska K, Kulig P, Baumert B and
Machaliński B: Brain-derived neurotrophic factor: Focus on the
pathogenesis of multiple myeloma and the development of
treatment-induced peripheral neuropathy. Leuk Lymphoma.
63:3044–3051. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lin CY, Hung SY, Chen HT, Tsou HK, Fong
YC, Wang SW and Tang CH: Brain-derived neurotrophic factor
increases vascular endothelial growth factor expression and
enhances angiogenesis in human chondrosarcoma cells. Biochem
Pharmacol. 91:522–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu YF, Jin KY, Wang DP, Lin Q, Sun J, Su
SH and Hai J: VEGF loaded nanofiber membranes inhibit chronic
cerebral hypoperfusion-induced cognitive dysfunction by promoting
HIF-1a/VEGF mediated angiogenesis. Nanomedicine. 48:1026392023.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Polacchini A, Albani C, Baj G, Colliva A,
Carpinelli P and Tongiorgi E: Combined cisplatin and aurora
inhibitor treatment increase neuroblastoma cell death but surviving
cells overproduce BDNF. Biol Open. 5:899–907. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee J, Jiffar T and Kupferman ME: A novel
role for BDNF-TrkB in the regulation of chemotherapy resistance in
head and neck squamous cell carcinoma. PLoS One. 7:e302462012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hua Z, Gu X, Dong Y, Tan F, Liu Z, Thiele
CJ and Li Z: PI3K and MAPK pathways mediate the BDNF/TrkB-increased
metastasis in neuroblastoma. Tumour Biol. 37:16227–16236. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li Z, Zhang J, Liu Z, Woo CW and Thiele
CJ: Downregulation of Bim by brain-derived neurotrophic factor
activation of TrkB protects neuroblastoma cells from paclitaxel but
not etoposide or cisplatin-induced cell death. Cell Death Differ.
14:318–326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jaboin J, Kim CJ, Kaplan DR and Thiele CJ:
Brain-derived neurotrophic factor activation of TrkB protects
neuroblastoma cells from chemotherapy-induced apoptosis via
phosphatidylinositol 3′-kinase pathway. Cancer Res. 62:6756–6763.
2002.PubMed/NCBI
|
|
49
|
Heinen TE, Dos Santos RP, da Rocha A, Dos
Santos MP, Lopez PL, Silva Filho MA, Souza BK, Rivero LF, Becker
RG, Gregianin LJ, et al: Trk inhibition reduces cell proliferation
and potentiates the effects of chemotherapeutic agents in Ewing
sarcoma. Oncotarget. 7:34860–34880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Okamura K, Harada T, Wang S, Ijichi K,
Furuyama K, Koga T, Okamoto T, Takayama K, Yano T and Nakanishi Y:
Expression of TrkB and BDNF is associated with poor prognosis in
non-small cell lung cancer. Lung Cancer. 78:100–106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lai J, Yang S, Lin Z, Huang W, Li X, Li R,
Tan J and Wang W: Update on chemoresistance mechanisms to
first-line chemotherapy for gallbladder cancer and potential
reversal strategies. Am J Clin Oncol. 46:131–141. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Brierley GV, Priebe IK, Purins L, Fung KY,
Tabor B, Lockett T, Nice E, Gibbs P, Tie J, McMurrick P, et al:
Serum concentrations of brain-derived neurotrophic factor (BDNF)
are decreased in colorectal cancer patients. Cancer Biomark.
13:67–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang Z, Wang S, Liu Y, Gao S, Yu Y and Hu
Z: Serum levels of BDNF in patients with adenoma and colorectal
cancer. Dis Markers. 2021:88673682021.PubMed/NCBI
|
|
54
|
Guzel T, Mech K, Iwanowska M, Wroński M
and Słodkowski M: Brain derived neurotrophic factor declines after
complete curative resection in gastrointestinal cancer. PeerJ.
9:e117182021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zoladz JA, Nowak LR, Majerczak J, Kulpa J,
Pilc A and Duda K: Breast cancer surgery decreases serum
brain-derived neurotrophic factor concentrations in middle aged
women: Relationship to the serum C-reactive protein concentration.
J Physiol Pharmacol. 70:doi: 10.26402/jpp.2019.4.01.
2019.PubMed/NCBI
|
|
56
|
Xiong X, Zeng M, Peng X, Feng C, Li C,
Weng W and Li Y: Serum brain-derived neurotrophic factor (BDNF) as
predictors of childhood neuroblastoma relapse. BMC Cancer.
23:6702023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kawamoto M, Ozono K, Oyama Y, Yamasaki A,
Oda Y and Onishi H: The novel selective pan-TRK inhibitor ONO-7579
exhibits antitumor efficacy against human gallbladder cancer in
vitro. Anticancer Res. 38:1979–1986. 2018.PubMed/NCBI
|
